Vontobel Holding
IBB icon

Vontobel Holding’s iShares Biotechnology ETF IBB Stock Holding History

Vontobel Holding’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$793K Buy
3,768
+1,694
+82% +$340K ﹤0.01% 905
2026
Q2 		$394K Sell
2,074
-75
-3% -$12.9K ﹤0.01% 1137
2026
Q1 		$363K Sell
2,149
-933
-30% -$160K ﹤0.01% 945
2025
Q4 		$520K Sell
3,082
-1,475
-32% -$240K ﹤0.01% 979
2025
Q3 		$658K Sell
4,557
-907
-17% -$124K ﹤0.01% 855
2025
Q2 		$691K Buy
5,464
+341
+7% +$41.9K ﹤0.01% 804
2025
Q1 		$655K Buy
5,123
+2,164
+73% +$293K ﹤0.01% 705
2024
Q4 		$391K Buy
2,959
+497
+20% +$69.9K ﹤0.01% 849
2024
Q3 		$358K Buy
2,462
+27
+1% +$3.91K ﹤0.01% 874
2024
Q2 		$334K Sell
2,435
-81
-3% -$10.8K ﹤0.01% 869
2024
Q1 		$345K Sell
2,516
-1,900
-43% -$259K ﹤0.01% 870
2023
Q4 		$600K Sell
4,416
-81
-2% -$9.9K 0.01% 749
2023
Q3 		$550K Sell
4,497
-2,877
-39% -$366K 0.01% 738
2023
Q2 		$936K Buy
7,374
+2,151
+41% +$279K 0.01% 615
2023
Q1 		$675K Sell
5,223
-2,588
-33% -$339K 0.01% 704
2022
Q4 		$1.03M Buy
7,811
+3,526
+82% +$456K 0.01% 575
2022
Q3 		$501K Sell
4,285
-1,441
-25% -$179K 0.01% 713
2022
Q2 		$674K Buy
5,726
+666
+13% +$79.1K 0.01% 637
2022
Q1 		$659K Buy
5,060
+440
+10% +$57.3K 0.01% 719
2021
Q4 		$705K Buy
4,620
+328
+8% +$50.8K 0.01% 722
2021
Q3 		$694K Sell
4,292
-9,467
-69% -$1.59M 0.01% 702
2021
Q2 		$2.25M Buy
13,759
+3,964
+40% +$611K 0.02% 411
2021
Q1 		$1.48M Buy
9,795
+7,395
+308% +$1.17M 0.01% 459
2020
Q4 		$364K Buy
+2,400
New +$343K ﹤0.01% 749

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return

Vontobel Holding's IBB Position: Q3 2026 in Review

Vontobel Holding increased its iShares Biotechnology ETF (IBB) stake by 82% in Q3 2026, buying an estimated $340K and bringing the position to 3,768 shares worth $793K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Vontobel Holding first reported a position in IBB in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.25M in Q2 2021. 646 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Vontobel Holding held 3,768 shares of iShares Biotechnology ETF worth $793K as of Q3 2026.
  • Vontobel Holding bought 1,694 iShares Biotechnology ETF shares in Q3 2026, an estimated $340K.
  • iShares Biotechnology ETF made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #905 holding.
  • Vontobel Holding first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 24 quarters since.
  • Vontobel Holding's iShares Biotechnology ETF position peaked at $2.25M in Q2 2021.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.